Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Ramathibiodi Hospital, Mahidol University, Bangkok, Thailand.
J Nutr Health Aging. 2012 Mar;16(3):246-51. doi: 10.1007/s12603-011-0343-7.
To identify genetic variations associated with parathyroid hormone (PTH) suppression after long-term calcium supplementation.
For high throughput SNP screening, subjects consisted of 171 postmenopausal women without osteoporosis at the lumbar spine. A separate group of 19 premenpausal women were recruited for calcium absorption study. Postmenopausal women in the screening group were given 500 mg/day calcium supplementation.
Bangkok, Thailand.
Parathyroid hormone (PTH) and bone mineral density (BMD) were measured at baseline and 2 years after calcium supplementation. High throughput single-nucleotide polymorphism (SNP) screening was performed by comparing estimated allele frequencies derived from hybridization signal intensities of pooled DNA samples on Affymetrix's 10K SNP genotyping microarrays based responsiveness in PTH after calcium supplementation. Genotyping of SNP rs1112482 in malic enzyme gene (ME1) gene, a SNP among those with highest odds ratio of being related to PTH suppression after calcium, was performed in all postmenopausal subjects in the screening group and premenopausal women in the calcium absorption study group in which fractional calcium absorption was assessed by stable isotope dilution. Data were expressed as mean +/- SEM.
PTH significantly decreased after 2 years of calcium supplementation (4.7 ± 1.9 vs. 4.4 ± 1.6 pmol/L, P < 0.01). There was a significant increase in lumbar spine BMD (1.03 ± 0.01 vs. 1.01 ± 0.01 g/cm2, P < 0.001) but not femoral neck BMD. In 108 subjects whose PTH levels decreased after calcium, the suppression of PTH was higher in those with at least one C allele in rs1112482 of ME1 gene (-26.3 ± 2.1 vs. -16.9 ± 1.4%, P < 0.001). Fractional calcium absorption also tends to the higher in subjects in the calcium absorption study group with at least one C allele (n = 6) compared to those without the C allele (n = 13) (58.0 ± 4.9 vs. 49.3 ± 2.8%, P = 0.054).
Cytosolic malic enzyme 1 gene polymorphism is associated with the degree of suppression of parathyroid hormone after long-term calcium supplementation. The effect is probably mediated through an increase in intestinal calcium absorption.
鉴定与长期钙补充后甲状旁腺激素(PTH)抑制相关的遗传变异。
为了进行高通量 SNP 筛查,研究对象包括 171 名无腰椎骨质疏松的绝经后妇女。招募了另外 19 名绝经前妇女进行钙吸收研究。在筛查组中,给予绝经后妇女每天 500 毫克的钙补充。
泰国曼谷。
在钙补充前和 2 年后测量甲状旁腺激素(PTH)和骨密度(BMD)。通过比较来自 Affymetrix 10K SNP 基因分型微阵列的混合 DNA 样本杂交信号强度得出的估计等位基因频率,对甲状旁腺激素对钙补充反应后的高吞吐量单核苷酸多态性(SNP)进行高通量 SNP 筛查。对筛选组中所有绝经后妇女和钙吸收研究组中进行苹果酸酶基因(ME1)基因中 SNPrs1112482 的基因分型,该 SNP 是与钙后 PTH 抑制相关的最高比值的 SNP 之一,并且在钙吸收研究组中通过稳定同位素稀释评估了分数钙吸收。数据表示为平均值 +/- SEM。
钙补充 2 年后 PTH 显著下降(4.7 ± 1.9 对 4.4 ± 1.6 pmol/L,P < 0.01)。腰椎 BMD 显著增加(1.03 ± 0.01 对 1.01 ± 0.01 g/cm2,P < 0.001),但股骨颈 BMD 没有增加。在 108 名 PTH 水平在钙后下降的受试者中,ME1 基因 rs1112482 中至少有一个 C 等位基因的受试者 PTH 抑制率更高(-26.3 ± 2.1 对-16.9 ± 1.4%,P < 0.001)。钙吸收研究组中至少有一个 C 等位基因(n = 6)的受试者的分数钙吸收也倾向于高于没有 C 等位基因的受试者(n = 13)(58.0 ± 4.9 对 49.3 ± 2.8%,P = 0.054)。
细胞质苹果酸酶 1 基因多态性与长期钙补充后甲状旁腺激素抑制的程度相关。这种作用可能是通过增加肠道钙吸收来介导的。